Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: Male patients with lower urinary tract symptoms have historically been managed in a prostate centric fashion. Population studies highlighting the prevalence and significance of storage symptoms, including nocturia, have meant a shift in the way men with lower urinary tract symptoms are assessed and managed. We review the recent guidelines and publications that have addressed this change in approach. RECENT FINDINGS: A new β-3 adrenoreceptor agonist has demonstrated significant improvement in storage symptoms and appears to be well tolerated. SUMMARY: We support a continued move towards a patient-focused and management using the current guidelines.
No takes yet. Share an insight, caveat, or question.
Warren et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: